10.46243/jst.2020.v5.i4.pp261-267 registered
Sphingosomes: A Novel Lipoidal Vesicular Drug Delivery System
Resolves to https://www.jst.org.in/index.php/pub/article/view/610
Held by Longman Publishers (India) · prefix 10.46243 live · DOI address https://doi.org/10.46243/jst.2020.v5.i4.pp261-267
Registered 29 Sep 2026 via crossref · record version 2 · last change 29 Sep 2026, 11:59 PM · record sha256 ecd0c91c0fa27d2e…
Resolve ⬇ Record (JSON) ⬇ Kernel Metadata Declaration (XML) Compare with Crossref Cite (APA · BibTeX · RIS · CSL)
Also as schema.org JSON-LD · Turtle · RDF/XML · DataCite XML (not for this record) · Crossref UNIXREF · Crossref UNIXSD — the formats of the DOI content-negotiation service, from this record (which carries what).
What the DOI identifies
JournalArticle — an article in a journal · Digital · Visual · en
Sphingosomes: A Novel Lipoidal Vesicular Drug Delivery System (PrincipalTitle · en)
Published 2020-07-30
Part of Journal of Science & Technology · ISSN 2456-5660 · issue Volume 5 · pages 261–267
Agents
- Longman Publishers (publisher)
Identifiers DOI 10.46243/jst.2020.v5.i4.pp261-267
Abstract · en
Vesicular drug delivery system has various advantages thereby improving therapeutic efficacy and by sustaining and controlling action of drugs. Liposomes, sphingosomes, ethosomes, cubosomes, pharmacasomes, niosomes, transferosomes are the newly developed vesicular drug delivery system. This review article mainly deals with the sphingosomal drug delivery system. Sphingosomes are vesicular drug delivery systems in which an aqueous volume is enclosed with sphingolipid bilayer membranes. Sphingosomes has an enhanced area of interest because of their applicability in improving the in vivo delivery of various chemotherapeutic agents, biological macromolecules and diagnostics. Sphingosome has major advantages over other vesicular drug delivery systems like high stability, more in vivo circulation time, high tumor loading efficacy in case of cancer therapy as compared to liposomes, niosomes etc. Sphingosomes are clinically used vesicular delivery system for chemotherapeutic agent, biological macromolecule and diagnostics. This review concluded that sphingosome represents a promising vesicular drug delivery system for a range of possible therapeutic applications.
System metadata — ISO 26324:2025, Annex B · DOI Handbook 10.1
Each element by the standard's name (Annex B: reference elements, then administrative) and the Handbook's (in grey), read off the record above.
| Element | Value | In the record |
|---|---|---|
| DOI Name DOI name | 10.46243/jst.2020.v5.i4.pp261-267 | doi |
| Referent Type referentType | Creation | referent |
| Referent Sub-Type referentSubType | JournalArticle — an article in a journal | type |
| Referent Name(s) referentName(s) | Sphingosomes: A Novel Lipoidal Vesicular Drug Delivery System (PrincipalTitle, en) | titles |
| Basic Metadata basicMetadata | publisher: Longman Publishers published: 2020-07-30 part of: Journal of Science & Technology · ISSN 2456-5660 · no. Volume 5 · pp. 261–267 language: en form: Digital · Visual · Language | agents, dates, container, language, structural_type, modes, characters |
| Referent Identifier(s) alternateIdentifier(s) | none besides the DOI | identifiers, relations (IsSameAs) |
| Registration Authority registrationAuthorityCode | Crossref — issued by Crossref (member 25296); held here as a copy | record.source_agency (our code, ra_doi_name, for names issued here once appointed) |
| Created Date issueDate | 2020-07-30 | record.registered (when the DOI name was first registered) |
| relatedIdentifiers | none needed — the descriptive metadata is in this record | container, relations (only where the descriptive metadata lives at another identifier) |
complete Every System Metadata element is here, with the basic metadata a journal article needs.
Recommended for a journal article and not in this record: its author(s), editor(s) or corporate author · the volume number.
The System Metadata Declaration (JSON) · the Kernel Metadata Declaration (XML) · what each sub-type needs
Cited by — in this registry
No record held in this registry cites this DOI.
Counts only records held in this registry; a citation from a work held elsewhere is not seen here. The list as JSON
References with DOIs
The record lists 35 references; 14 carry a DOI.
| # | Reference | DOI | Held here |
|---|---|---|---|
| 1 | ref1 Mohd. Gayoor K han. Topic-The novel drug delivery system. World journal of pharmacy and pharmaceutical sciences, 2017; 6(7): 477-487 | 10.20959/wjpps20177-9607 | not held here |
| 5 | ref5 Molema G, Meijer DKF. Drug Targeting Organ-Specific Strategies. Wiley-VCH Verlag GmbH, 2001: 157–170 | 10.1002/352760006x | not held here |
| 7 | ref7 Shailza Singh et al. Molecular drug targets and structure based drug design: A holistic approach. Bioinformation, 2006; 1(8): 314-320 | 10.6026/97320630001314 | not held here |
| 9 | ref9 MayankGangwar, Ragini Singh, Goel RK, Gopalnath. Recent Advances in various emerging vesicular system: An Overview. Asian Pacific Journal of Tropical Biomedicine, 2012:1-4 | 10.1016/s2221-1691(12)60381-5 | not held here |
| 13 | ref13 Kumar D, Sharma D, Singh G, Singh M, Rathore M. S, Lipoidal soft hybrid biocarriers of supramolecular construction for drug delivery, International Scholar of research network pha… | 10.5402/2012/474830 | not held here |
| 17 | ref17 Shailza S. Molecular drug targets and structure based design: A holistic approach, bioinformation, 2006; 1(8): 314-320 | 10.6026/97320630001314 | not held here |
| 24 | ref24 Papahadjo P.D, Vail W.J, Ann N.Y, Acad Sci. 308, 1978, 259. 26 | 10.1111/j.1749-6632.1978.tb22028.x | not held here |
| 28 | ref28 Abhishek C, Ethosomes: A novel approach towards transdermal drug delivery, 2012; 1(2): 565 | 10.1002/9781119959687.ch1 | not held here |
| 29 | ref29 Pooja V, Ethosomes: A novel drug carrier for transdermal drug delivery. IJPRSBS, 2012; 1(6): 1-9 | 10.1002/9781119959687.ch1 | not held here |
| 31 | ref31 Dave V, Dhirondra K. Ethosome for enhanced transdermal drug delivery of aceclofenac, International journal of drug delivery, 2015;2:81-83 | 10.5138/ijdd.2010.0975.0215.02016 | not held here |
| 32 | ref32 Rodriquez et al. Vincristine sulphate liposomes injection ( Marqibo) in heavily pretreated patients with refractory aggressive non hodgkin lymphoma: report of the pivotal phase 2 … | 10.1002/cncr.24359 | not held here |
| 33 | ref33 Sphingosomes Moist LS 9871–for optimal skin purifying with moisturizing and skin barrier strengthe ning benefits. SpecialChem.2009 | 10.1016/s1351-4210(10)70011-1 | not held here |
| 34 | ref34 Mathew B et al. Role of sphingolipids in murine radiation-induced lung injury: protection by sphingosine 1-phosphate analogs. Faseb J. 2011;25(10):3388-400 | 10.1096/fj.11-183970 | not held here |
| 35 | ref35 Baumruker T, Prieschl EE. Sphingolipids and the regulation of the immune response. Seminimmunol. 2002;14(1):57-63 | 10.1006/smim.2001.0342 | not held here |
Relations
The record states no relation, and no record held here states one with this DOI.
Funding
The record names no funder.
Each funder's page lists every work held here that names it. ROR IDs open at ror.org; Funder Registry IDs resolve at doi.org.
History — the ledger
Every change to this DOI, in order, as it was recorded. Entries are only ever added, never changed or removed.
| # | When | What | By | Changes |
|---|---|---|---|---|
| 1 | 29 Sep 2026, 10:00 PM | register registered at Crossref; record read from api.crossref.org | Administrator (admin) | 131 fields set · sha256 25442086141f… |
| 2 | 29 Sep 2026, 11:59 PM | update record re-read from api.crossref.org | Administrator (admin) | container.titles.0.value: |
Machine-readable: the history as JSON, with the full record after each change.



